Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients
- 1 April 2001
- journal article
- other
- Published by Elsevier in Schizophrenia Research
- Vol. 49 (1-2), 223-225
- https://doi.org/10.1016/s0920-9964(99)00147-4
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Association of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophreniaBiological Psychiatry, 1997
- Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patientsMolecular Psychiatry, 1997
- PCR detection of the TaqA RFLP at the DRD2 locusHuman Molecular Genetics, 1993
- Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disordersPsychiatric Genetics, 1992
- Drug-Resistance Phenomena in Major Psychoses: Their Discrimination and Causal MechanismsClinical Neuropharmacology, 1990